Inside Neuroelectrics, the brain science start-up hoping to curb epilepsy and depression

The following is a transcript of the video.

High up in the hills of the Catalan capital, Neuroelectrics is developing therapies that it says will improve the lives of people living with brain disease. The group manufactures around 400 devices which it ships to 75 different countries worldwide each year. Everything from research to production and assembly takes place here. Ana Maiques is co-founder and CEO of Neuroelectrics.

ARJUN KHARPAL: Ana, thank you very much for having CNBC here today. Tell me about the products you make here.

ANA MAIQUES: Our main product is the cap that has up to 32 electrodes and what is innovative about our platform is that any of the electrodes or sensors that I put over my head have the potential to either monitor or stimulate your brain.

KHARPAL: What are the applications and treatments that the headgear can be used for?

MAIQUES: Our main indication today is epilepsy. In the world, there are 60 million patients suffering from epilepsy and one-third of those don't respond to medication. So, these patients usually go into surgery, either a craniotomy — we remove the part of the brain that is creating the seizures — or an implanted device. So Neuroelectrics is bringing this noninvasive solution to try to reduce seizures.

Based on Neuroelectrics' trials with the FDA, a patient with epilepsy would require ten daily 20-minute sessions for around eight weeks for its therapy to work. In the future, it's hoped the headgear could also be used to treat depression and Alzheimer's. So far, the group has conducted an open label study using 35 patients suffering from depression.

MAIQUES: Our business and commercialization strategy is to really make sure that our therapy is approved by the medical authorities